Cubist Systematic Strategies LLC purchased a new position in shares of TriMas Co. (NASDAQ:TRS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 35,890 shares of the industrial products company's stock, valued at approximately $883,000. Cubist Systematic Strategies LLC owned approximately 0.09% of TriMas at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in TRS. Bank of America Corp DE grew its stake in TriMas by 127.3% during the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock worth $86,400,000 after buying an additional 1,967,738 shares in the last quarter. Bellecapital International Ltd. bought a new stake in shares of TriMas in the 4th quarter valued at $29,160,000. Raymond James Financial Inc. bought a new stake in TriMas during the 4th quarter valued at $6,698,000. Kennedy Capital Management LLC increased its stake in TriMas by 94.8% during the 4th quarter. Kennedy Capital Management LLC now owns 485,721 shares of the industrial products company's stock valued at $11,944,000 after purchasing an additional 236,346 shares in the last quarter. Finally, Advisory Research Inc. boosted its holdings in TriMas by 41.2% during the 4th quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock worth $18,543,000 after acquiring an additional 220,000 shares during the last quarter. 99.42% of the stock is owned by institutional investors.
Insider Buying and Selling
In other news, CFO Scott A. Mell sold 2,218 shares of the stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $22.54, for a total transaction of $49,993.72. Following the completion of the sale, the chief financial officer now owns 26,288 shares of the company's stock, valued at approximately $592,531.52. This represents a 7.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeffrey A. Fielkow acquired 2,500 shares of the company's stock in a transaction dated Friday, February 28th. The shares were bought at an average cost of $20.78 per share, with a total value of $51,950.00. Following the purchase, the director now owns 11,013 shares of the company's stock, valued at approximately $228,850.14. This trade represents a 29.37% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 929,729 shares of company stock worth $22,280,897. Insiders own 14.20% of the company's stock.
Analysts Set New Price Targets
Separately, BWS Financial reissued a "buy" rating and issued a $40.00 price target on shares of TriMas in a report on Wednesday, April 30th.
View Our Latest Research Report on TRS
TriMas Price Performance
Shares of TRS traded down $0.36 during midday trading on Tuesday, hitting $25.46. 30,126 shares of the company traded hands, compared to its average volume of 325,633. The stock has a 50-day moving average of $22.91 and a 200-day moving average of $24.04. TriMas Co. has a one year low of $19.33 and a one year high of $28.51. The firm has a market cap of $1.03 billion, a P/E ratio of 39.75 and a beta of 0.58. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44.
TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.03. The company had revenue of $241.67 million for the quarter, compared to analysts' expectations of $235.41 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. TriMas's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.37 earnings per share. As a group, sell-side analysts predict that TriMas Co. will post 1.69 EPS for the current fiscal year.
TriMas Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th were given a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.63%. The ex-dividend date was Tuesday, May 6th. TriMas's dividend payout ratio (DPR) is 20.78%.
About TriMas
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
See Also

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report